
==== Front
J Clin Endocrinol Metab
J Clin Endocrinol Metab
jcem
The Journal of Clinical Endocrinology and Metabolism
0021-972X
1945-7197
Oxford University Press US

10.1210/clinem/dgae429
dgae429
Correction
AcademicSubjects/MED00250
Correction to: “Zoledronate After Denosumab Discontinuation: Is Repeated Administrations More Effective Than Single Infusion?”
10 2024
01 7 2024
01 7 2024
109 10 e1986e1986
01 7 2024
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society.
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. See the journal About page for additional terms.
==== Body
pmcIn the above-named article by Grassi G, Ghielmetti A, Zampogna M, Chiodini I, Arosio M, Mantovani G, and Eller-Vainicher C (J Clin Endo Metab. 2024; doi: 10.1210/clinem/dgae224), there was an error in the Funding section.

In the originally published article, the Funding section was not present. In the corrected article, the Funding section reads: “The authors declare that financial support was received for the publication of this article. This study was partially supported by Ricerca Corrente funds from the Italian Ministry of Health to Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico.”

The article has been corrected online.

doi: 10.1210/clinem/dgae224
